Western Digital's Q4 Earnings Ahead: Key Trends Investors Should Watch — Negative
WDC Zacks Investment Research — July 28, 2025WDC eyes sequential revenue growth in fiscal Q4 2025, fueled by cloud demand, AI-driven storage and a $2B buyback in place amid cost pressures.

S&P Global to Report Q2 Earnings: Here's What You Should Know — Positive
SPGI Zacks Investment Research — July 28, 2025SPGI's second-quarter 2025 earnings are expected to have risen on strong product demand, market positioning and recurring revenue gains.

Home BancShares (HOMB) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? — Positive
HOMB Zacks Investment Research — July 28, 2025Home BancShares (HOMB) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

How Much Upside is Left in Kennedy-Wilson (KW)? Wall Street Analysts Think 30.26% — Positive
KW Zacks Investment Research — July 28, 2025The consensus price target hints at a 30.3% upside potential for Kennedy-Wilson (KW). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Should You Buy Alphabet Inc. (GOOG) After Golden Cross? — Positive
GOOG GOOGL Zacks Investment Research — July 28, 2025After reaching an important support level, Alphabet Inc. (GOOG) could be a good stock pick from a technical perspective. GOOG recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

Wall Street Analysts Believe Revolution Medicines (RVMD) Could Rally 90.58%: Here's is How to Trade — Positive
RVMD Zacks Investment Research — July 28, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 90.6% in Revolution Medicines (RVMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts See a 60.15% Upside in Geo Group (GEO): Can the Stock Really Move This High? — Positive
GEO Zacks Investment Research — July 28, 2025The mean of analysts' price targets for Geo Group (GEO) points to a 60.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Enovix Corporation (ENVX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now — Positive
ENVX Zacks Investment Research — July 28, 2025Enovix Corporation (ENVX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEM — Neutral
TEM GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating MediaAlpha Inc. for potential violations of securities laws — Neutral
MAX GlobeNewsWire — July 28, 2025PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION

Fubo Sees Disney, Hulu + Live TV Deal Closing Earlier Than Anticipated — Positive
DIS FUBO Deadline — July 28, 2025Fubo has accelerated the expected timeline for closing its sale to Disney, now anticipating the transaction will close in the fourth quarter of this year or the first three months of 2026. It requires regulatory approval with a review ongoing at the Department of Justice.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT — Neutral
SRPT GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS — Neutral
HIMS GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Can Optum Support UnitedHealth's Profit Amid Industry Headwinds? — Negative
UNH Zacks Investment Research — July 28, 2025UNH leans on Optum's diversified growth and value-based care to counter insurance sector margin pressure in Q2.

Bank of Marin (BMRC) Q2 Earnings Miss Estimates — Negative
BMRC Zacks Investment Research — July 28, 2025Bank of Marin (BMRC) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.06 per share a year ago.

Here's Why BOK Financial (BOKF) is a Strong Momentum Stock — Positive
BOKF Zacks Investment Research — July 28, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Exelixis (EXEL) is a Strong Momentum Stock — Positive
EXEL Zacks Investment Research — July 28, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Barrick Mining (B) is a Strong Momentum Stock — Positive
B Zacks Investment Research — July 28, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Dentsply International (XRAY) is a Strong Momentum Stock — Positive
XRAY Zacks Investment Research — July 28, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

These Analysts Cut Their Forecasts On Charter Communications Following Q2 Earnings — Negative
CHTR Benzinga — July 28, 2025Charter Communications, Inc. CHTR reported a second-quarter EPS miss on Friday.
